Embed code
Note: this content has been automatically generated.
um so today i'll be talking to rouse solutions that the file
and what we want to be in what we aim to be is a fully independent solution
that's it's within the health economy to facilitate the shift value
based health care and improves aside the well being
we are trying to develop a global solution um and we have a
partnership with swiss calm while our technical and developmental partners to provide
us with the ball chain development will uh also joining the action checkup
and we also have some numerous uh industry partnerships as well
um so i'm i'm sure with the healthcare background y'all have you're all aware
of some of the main problems you know facing societies as a whole
health care yeah is faced with on sustainable expenditure and this is due to eighteen populations
rising prevalence of of chronic diseases and rising treatment costs
and we also see that healthcare is moving towards personalisation like the previous presenter has said
and this is resulted in in a barrier to market access for manufacturers for the innovative therapies
we see health authorities in shores can't afford to pay for these new high
cost therapies this also results in barriers to access for patients as well
so patients often the night these lifesaving therapies well they have to pay for therapies
it doesn't work and we see that this is quite an unfair system
and we see the who well there's moving forward value based health care and value
based uh health deals of being struck internationally of the last few years
let's take one example metro naked zero value basically isn't two thousand seventeen
in two thousand eighteen they have more than a thousand the like to estimate that more
than seventy five percent of health care payments by twenty twenty will be value based
and what is value based healthcare value based half k. is paying for performance
and no longer pay in for service or paying for volume
so we only pay the full price if the treatment gives good patient outcomes
but one of the main problems with we see with value based health
care and value based pricing is the infrastructure limitations of actually
implementing this and this is the main problem that we seek to
solve so some of the key problems is trusting transparency
because payment for health care is now based on outcomes it's all about
what the results of the treatments are these can easily be manipulated
by either party and this is one problem we currently see
there's also the privacy and security of these pricing agreements the administrative burden that's associated with
tracking patience patience start treatments at different times they reach different events in different times
and combining these with different pricing agreement as well the re conciliation is
it's quite a big administrative bit than an essentially the costs of doing this
negates all the cost benefit of actually moving to a value based approach
what we also see our technical limitations so the ability to follow patients as
they move across different treatment centres we also have issues with time delays
of reimbursement because of this currently in some countries
uh let's take i learned for example last year hepatitis c. patients were not able to get
treatment for a period of six to eight weeks 'cause there's a rebate mechanism in place
where at a manufacturer will hold a funds that they given by the player
until the outcomes are completely check through in the fine and then that a
discount or or refund the sent back and this is an unsustainable model
and we also see that there is no one single platform that anybody can use
so what did you farm we utilise blocking technology to create
that data integrity and a mute ability around outcomes
so everybody knows that this is the one true vision of events and
everybody within that network has a copy of of that uh data
we also understand that privacy and security of
pricing agreements is is key essentially
clinical trials data yes that's confidential but essential that that
that's always published into the public domain where
is next prices and discounts uh i things that the never essentially released into the public
and so we use private permission block chains well only those
actors within that network have access to that data
we also eliminated ministry to bit in using smart contract
so smart contracts a digital representations of physical
contracts well we can entities pricing agreements
and these are able to be executed automatically according to the data systems that these link
to so in healthcare this would be health information system or clinical data registry
we also use digital identities and not be spoke integration engines to be
able to track patients across different treatment centres and because combining all
of this were able to create is real time reinvestment in settlement
mechanisms on we're able to create this one single global platform
for farmer company they can use in every country day trying to gain access to and for
pay or they can use that to every manufacturer provider they have value based agreements with
so one of our flagship solutions is the real based platform and taking all that
i've said into account you can now create very complex and personalise pricing agreements
whether it's a price agreement for an oncology drug that's based on survival
well whether it's an agreement that include survival the serious adverse events of interest
a re hospital association rate or any other surrogate endpoint that's collected by some sort
of digital device no matter how many conditions you place in this agreement
the administrative been does not change and this is something that we see
is very important so we've set up our system to be fully
flexible fully customisable to work within any type of healthcare system whether
to single payer system like the u. k. n. h. s.
whether it's a and and uh but don't think shows base system like we seen sweets and
well we can also look at 'em systems where patients but don t. pay for their house cat
outright with out of pocket payments i i and this is an example of a manufacturer dashboard
so many factors and and anybody within the network is able to customise these platforms and
include the key performance indicators how they wish and we have certain access management facilities
so only for example if you are not pharmaceutical company only the the the pricing
team or the health economics team will be able to see this pricing
data rows of the you know clinical departments can actually see key product performance
and the other indicators so in regards to lodge any so far
um we have many pilots in planning with several international health authorities
um cross three conference continents um and we're in negotiations and discussions with certain pilots
what ate up the top ten pharmaceutical companies were also reaching it
to work with a community care providers and social care
as we see value based commissioning in that area is huge as essentially
eh in community can social care outcomes and not being tracked and these
are populations especially the elderly that have the highest cost within
uh for health systems uh and we're also working with
channel mic sequencing partners to get patients to participate
on some of our platforms to receive three gentlemen profiling i'll get that get to that later
i'm sorry lost our road map uprising platform will be ready within the next
four weeks ready to kick off pilots but the minimum bible network
um we hope to have three very significant large
scale pilots with the minimum bible network
uh by the end of two thought so completed by the end of two thousand
nineteen and a minimum bible network is is those for example uh uh pay a manufacturer
and uh provide that we'll have a series of smaller pilots when we need
um and we seek to have an international roll out by early two thousand nineteen as we are the first independent
a pricing platform uh on the market at the moment i so because we are able to
integrate and link into sits in health information systems
we want to provide patients you opportunity
to be rewarded for sharing their health data and create a real well evidence database
um and this is a database that will be actors repository for global
data and this is something that's currently missing in health care
um hum and through that we also want to create the did you have platform 'cause this is
the actual application where patients can actually manage their
data they can give access to whatever organisations
the uh you know they would they wish to um patients with with some
of this uh data that's in the monster data for red diseases
if that date is accessed more than these uh patience will be
rewarded more as well so we're creating these digital nuggets essentially
and way using the block chain to be able to track our
g. d. p. r. compliance as well to see where this data is being used who's looked at it
um and also using that as a mechanism for regime as well
this is also platform where patients can be identified by organisations
who seek to a recruit them for a clinical
research studies one additional platform we have is a a
platform pulled of all four crowd funding innovations so
digital asset position and talk in isolation using watching technology to a really effort trot funding value
medical innovation so giving people the public the opportunity to invest in early half technology
and giving a these organisations to receive money quite easily to develop
their products if um and that's it uh thank you
i think you know the question only one
okay willow a ticket from of people and it was big and uh one question
but if you're gonna an important one though it's the the dipper are related
those so used to those some bucks that's in contradictory the
uh with the real to deploy or or buttons
the blue blue's will be a little more or expose it on how exactly
alluded bread compliant but integrating a pageant uh that uh for instance
and the um cody room sure go right to the blue forgotten in regards to which platform to to
your or probably proposal to room norman probably pop proposal
so our main product proposals the pricing platform
and within g. d. p. all the special section for paying for health care um and essentially
the data we poll is essentially all anonymous anyway um so that i sort anonymous
um well i mean to be honest i mean anonymous anonymous them under the way i say it
is essentially the same but that's with the technical teams will do it right i mean
what we need a a a for for paying for health care i mean you don't
need the patient id to pay for the health care we're creating the digital tag
to the certain fields so we can use utilise in utilise nation data and things like that
and also when you start aggregate think data as well then this
ways to actually um use that to paying for health care
yeah no i mean them so that the innate no no i understand understand so we sent to we don't hold
any of this data on the block chain or anything like this this is all held off chain as well
and we have the block chain hold hash is which point to where the status as essentially help
it is a lot less that would get your it you look us dollars
though we don't normal okay so thank you all for the presentation

Share this talk: 


Conference program

Mots de bienvenue
Sébastien Mabillard, CEO | Swiss Digital Health
15 June 2018 · 9:07 a.m.
Mots de bienvenue
Victor Fournier, Chef de Service de la santé publique | Canton du Valais
15 June 2018 · 9:11 a.m.
Mots de bienvenue
Jean-Albert Ferrez, Président | Fondation The Ark
15 June 2018 · 9:19 a.m.
Mots de bienvenue
Laurent Sciboz, directeur Institut Informatique de Gestion | HES-SO Valais/Wallis
15 June 2018 · 9:24 a.m.
L'écosystème d'innovation ouverte du CHU Sainte-Justine: une grande communauté gagnante!
Kathy Malas, resp. de la Plateforme de l’innovation et des Fonctions des maladies chroniques et aiguës | CHU SAINTE-JUSTINE (Canada)
15 June 2018 · 9:33 a.m.
Les livraisons par drones : vers une amélioration de la logistique dans le domaine médical
Janick Mischler, Program Manager | LA POSTE SUISSE
15 June 2018 · 10:07 a.m.
E-health et intégration des soins
Marc Cikes, CEO | MEDBASE ROMANDIE (Suisse)
15 June 2018 · 10:32 a.m.
Questions réponses
Remi Gauchoux, Business Development Director - Carenity
15 June 2018 · 11:46 a.m.
Futur de la santé mobile
Dr. med. Patricia Sigam, CEO & Co-founder, digital Med-Lab
15 June 2018 · 11:54 a.m.
Democratizing Data-Driven Medicine
Tarik Dlala, VP Marketing, Sophia Genetics
15 June 2018 · 12:14 p.m.
Ada inside
Vincent Zimmer, Ada Health, Berlin
15 June 2018 · 12:39 p.m.
biospectal, the optical revolution in hypertension monitoring
Prof. Patrick Schoettker, CMO. Biospectal
15 June 2018 · 2:06 p.m.
3D Printed Medicines: A Digital Pharmacy Era
Sarah Trenfield, MPharm, Senior Formulation Scientist, FabRx Ltd.
15 June 2018 · 2:23 p.m.
The Digipharm experience
Ahmed Abdullah, CEO & co-founder, Digipharm, Basel
15 June 2018 · 2:45 p.m.
Enabling the rehabilitative revolution
Dr. Manfredo Atzori, HES-SO Valais Wallis
15 June 2018 · 3 p.m.
Team Gamified Multi-sensory Stroke Rehab
Jean-Luc Turlan et J-P. Ghobril, Lauréats Arkathon 2018
15 June 2018 · 3:22 p.m.
Secure and Trustable EMR Sharing using Blockchain: Open Challenges and Lessons Learned
Alevtina Dubovitskaya, HES-SO Valais-Wallis
15 June 2018 · 3:38 p.m.
Conclusions
Sébastien Mabillard, CEO | Swiss Digital Health
15 June 2018 · 3:59 p.m.

Recommended talks

La vision d’Agfa HealthCare, France
Jörg Schwarz, Global Business Development, Agfa HealthCare
6 June 2014 · 10:23 a.m.
Human Centric Innovation in Action - Exploiting the Internet of Things
Ian Thomas, CMO, Fujitsu RunMyProcess
30 Jan. 2015 · 2:50 p.m.